Global Pain Patches Market
Global Pain Patches Market

Pain Patches Comprehensive Study by Type (Opioid Patches, Non-Opioid), Mode of Administration (Minimally Invasive Microneedle Patches, Metered Doses, Active Delivery Systems with Patches), Distribution Channel (Hospitals, Drug Stores, Retail Pharmacies, Online Pharmacies), Therapeutic Use (Pain relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Smoking Cessation) Players and Region - Global Market Outlook to 2026

Pain Patches Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jun 2021 Edition 219 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Pain Patches Market Scope?
Pain patches market expected to register significant growth over the forecast period as increasing demand for non-opioid drugs for pain management. Opioid drugs are commonly prescribed for the treatment of pain and related disorders which resulting in dependency on opioids in the majority of patients. Rising opioid addiction has encouraged to move towards alternative therapies or non-opioid-based treatment. Nowadays, healthcare professionals are inclining towards non-opioid-based therapy or drugs as higher awareness among them related to opioid dependency. Therefore, pain patches expected to gain greater adoption over the machines as the benefits of reduction in pain patches is more.

The Pain Patches market study is being classified by Type (Opioid Patches and Non-Opioid) and major geographies with country level break-up.

Pain patches market is a highly fragmented market. Various companies are focusing on the development of pain patches for pain management. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Pain Patches market throughout the predicted period.

Purdue Pharma L.P (United States), Janssen Pharmaceuticals, Inc (Belgium), West-Ward Pharmaceuticals Corporation (United States), Pfizer, Inc. (United States), Allergan Plc (Actavis) (Ireland), Sanofi-Aventis S.A. (France), Endo International plc (Ireland), GlaxoSmithKline plc (United States), Hisamitsu Pharmaceutical Co., Inc (Japan) and Mylan N.V. (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Pain Patches market by Type, Application and Region.

On the basis of geography, the market of Pain Patches has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • The Increasing Number of Sport-Related Injuries
  • Rising Usage of Opioids in Non-Cancer Conditions

Market Drivers
  • Growing Chronic and Acute Pain Related Disorders
  • Increasing Prevalence of Arthritis and Post-Herpetic Neuralgia

Opportunities
  • Rising Research and Development in This Field

Restraints
  • High Price of The Pain Patches

Challenges
  • Presence Of Competitors


Key Target Audience
Manufacturers of Pain Patches, Suppliers and distributors of Pain Patches, Governmental and Regulatory bodies and End-Users

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Pain Patches market expands?
The Global Pain Patches market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Pain Patches market?
The prominent players of Global Pain Patches market are Purdue Pharma L.P (United States), Janssen Pharmaceuticals, Inc (Belgium), West-Ward Pharmaceuticals Corporation (United States), Pfizer, Inc. (United States), Allergan Plc (Actavis) (Ireland), Sanofi-Aventis S.A. (France), Endo International plc (Ireland), GlaxoSmithKline plc (United States), Hisamitsu Pharmaceutical Co., Inc (Japan) and Mylan N.V. (United States), to name a few.

3. What are the top priorities to focus for Pain Patches marketís growth?
In this highly competitive & fast evolving Pain Patches industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Type
  • Opioid Patches
  • Non-Opioid
By Mode of Administration
  • Minimally Invasive Microneedle Patches
  • Metered Doses
  • Active Delivery Systems with Patches

By Distribution Channel
  • Hospitals
  • Drug Stores
  • Retail Pharmacies
  • Online Pharmacies

By Therapeutic Use
  • Pain relief
  • Anesthesia
  • Cough Suppression
  • Diarrhea Suppression
  • Smoking Cessation

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Chronic and Acute Pain Related Disorders
      • 3.2.2. Increasing Prevalence of Arthritis and Post-Herpetic Neuralgia
    • 3.3. Market Challenges
      • 3.3.1. Presence Of Competitors
    • 3.4. Market Trends
      • 3.4.1. The Increasing Number of Sport-Related Injuries
      • 3.4.2. Rising Usage of Opioids in Non-Cancer Conditions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pain Patches, by Type, Mode of Administration, Distribution Channel, Therapeutic Use and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pain Patches (Value)
      • 5.2.1. Global Pain Patches by: Type (Value)
        • 5.2.1.1. Opioid Patches
        • 5.2.1.2. Non-Opioid
      • 5.2.2. Global Pain Patches by: Mode of Administration (Value)
        • 5.2.2.1. Minimally Invasive Microneedle Patches
        • 5.2.2.2. Metered Doses
        • 5.2.2.3. Active Delivery Systems with Patches
      • 5.2.3. Global Pain Patches by: Distribution Channel (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Drug Stores
        • 5.2.3.3. Retail Pharmacies
        • 5.2.3.4. Online Pharmacies
      • 5.2.4. Global Pain Patches by: Therapeutic Use (Value)
        • 5.2.4.1. Pain relief
        • 5.2.4.2. Anesthesia
        • 5.2.4.3. Cough Suppression
        • 5.2.4.4. Diarrhea Suppression
        • 5.2.4.5. Smoking Cessation
      • 5.2.5. Global Pain Patches Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Pain Patches: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Purdue Pharma L.P (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Janssen Pharmaceuticals, Inc (Belgium)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. West-Ward Pharmaceuticals Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Allergan Plc (Actavis) (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sanofi-Aventis S.A. (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Endo International plc (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GlaxoSmithKline plc (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hisamitsu Pharmaceutical Co., Inc (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Mylan N.V. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pain Patches Sale, by Type, Mode of Administration, Distribution Channel, Therapeutic Use and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pain Patches (Value)
      • 7.2.1. Global Pain Patches by: Type (Value)
        • 7.2.1.1. Opioid Patches
        • 7.2.1.2. Non-Opioid
      • 7.2.2. Global Pain Patches by: Mode of Administration (Value)
        • 7.2.2.1. Minimally Invasive Microneedle Patches
        • 7.2.2.2. Metered Doses
        • 7.2.2.3. Active Delivery Systems with Patches
      • 7.2.3. Global Pain Patches by: Distribution Channel (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Drug Stores
        • 7.2.3.3. Retail Pharmacies
        • 7.2.3.4. Online Pharmacies
      • 7.2.4. Global Pain Patches by: Therapeutic Use (Value)
        • 7.2.4.1. Pain relief
        • 7.2.4.2. Anesthesia
        • 7.2.4.3. Cough Suppression
        • 7.2.4.4. Diarrhea Suppression
        • 7.2.4.5. Smoking Cessation
      • 7.2.5. Global Pain Patches Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pain Patches: by Type(USD Million)
  • Table 2. Pain Patches Opioid Patches , by Region USD Million (2015-2020)
  • Table 3. Pain Patches Non-Opioid , by Region USD Million (2015-2020)
  • Table 4. Pain Patches: by Mode of Administration(USD Million)
  • Table 5. Pain Patches Minimally Invasive Microneedle Patches , by Region USD Million (2015-2020)
  • Table 6. Pain Patches Metered Doses , by Region USD Million (2015-2020)
  • Table 7. Pain Patches Active Delivery Systems with Patches , by Region USD Million (2015-2020)
  • Table 8. Pain Patches: by Distribution Channel(USD Million)
  • Table 9. Pain Patches Hospitals , by Region USD Million (2015-2020)
  • Table 10. Pain Patches Drug Stores , by Region USD Million (2015-2020)
  • Table 11. Pain Patches Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 12. Pain Patches Online Pharmacies , by Region USD Million (2015-2020)
  • Table 13. Pain Patches: by Therapeutic Use(USD Million)
  • Table 14. Pain Patches Pain relief , by Region USD Million (2015-2020)
  • Table 15. Pain Patches Anesthesia , by Region USD Million (2015-2020)
  • Table 16. Pain Patches Cough Suppression , by Region USD Million (2015-2020)
  • Table 17. Pain Patches Diarrhea Suppression , by Region USD Million (2015-2020)
  • Table 18. Pain Patches Smoking Cessation , by Region USD Million (2015-2020)
  • Table 19. South America Pain Patches, by Country USD Million (2015-2020)
  • Table 20. South America Pain Patches, by Type USD Million (2015-2020)
  • Table 21. South America Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 22. South America Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 23. South America Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 24. Brazil Pain Patches, by Type USD Million (2015-2020)
  • Table 25. Brazil Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 26. Brazil Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 27. Brazil Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 28. Argentina Pain Patches, by Type USD Million (2015-2020)
  • Table 29. Argentina Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 30. Argentina Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 31. Argentina Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 32. Rest of South America Pain Patches, by Type USD Million (2015-2020)
  • Table 33. Rest of South America Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 34. Rest of South America Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 35. Rest of South America Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 36. Asia Pacific Pain Patches, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Pain Patches, by Type USD Million (2015-2020)
  • Table 38. Asia Pacific Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 39. Asia Pacific Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 40. Asia Pacific Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 41. China Pain Patches, by Type USD Million (2015-2020)
  • Table 42. China Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 43. China Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 44. China Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 45. Japan Pain Patches, by Type USD Million (2015-2020)
  • Table 46. Japan Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 47. Japan Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 48. Japan Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 49. India Pain Patches, by Type USD Million (2015-2020)
  • Table 50. India Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 51. India Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 52. India Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 53. South Korea Pain Patches, by Type USD Million (2015-2020)
  • Table 54. South Korea Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 55. South Korea Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 56. South Korea Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 57. Taiwan Pain Patches, by Type USD Million (2015-2020)
  • Table 58. Taiwan Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 59. Taiwan Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 60. Taiwan Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 61. Australia Pain Patches, by Type USD Million (2015-2020)
  • Table 62. Australia Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 63. Australia Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 64. Australia Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Pain Patches, by Type USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 69. Europe Pain Patches, by Country USD Million (2015-2020)
  • Table 70. Europe Pain Patches, by Type USD Million (2015-2020)
  • Table 71. Europe Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 72. Europe Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 73. Europe Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 74. Germany Pain Patches, by Type USD Million (2015-2020)
  • Table 75. Germany Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 76. Germany Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 77. Germany Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 78. France Pain Patches, by Type USD Million (2015-2020)
  • Table 79. France Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 80. France Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 81. France Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 82. Italy Pain Patches, by Type USD Million (2015-2020)
  • Table 83. Italy Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 84. Italy Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 85. Italy Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 86. United Kingdom Pain Patches, by Type USD Million (2015-2020)
  • Table 87. United Kingdom Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 88. United Kingdom Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 89. United Kingdom Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 90. Netherlands Pain Patches, by Type USD Million (2015-2020)
  • Table 91. Netherlands Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 92. Netherlands Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 93. Netherlands Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 94. Rest of Europe Pain Patches, by Type USD Million (2015-2020)
  • Table 95. Rest of Europe Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 96. Rest of Europe Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 97. Rest of Europe Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 98. MEA Pain Patches, by Country USD Million (2015-2020)
  • Table 99. MEA Pain Patches, by Type USD Million (2015-2020)
  • Table 100. MEA Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 101. MEA Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 102. MEA Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 103. Middle East Pain Patches, by Type USD Million (2015-2020)
  • Table 104. Middle East Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 105. Middle East Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 106. Middle East Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 107. Africa Pain Patches, by Type USD Million (2015-2020)
  • Table 108. Africa Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 109. Africa Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 110. Africa Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 111. North America Pain Patches, by Country USD Million (2015-2020)
  • Table 112. North America Pain Patches, by Type USD Million (2015-2020)
  • Table 113. North America Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 114. North America Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 115. North America Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 116. United States Pain Patches, by Type USD Million (2015-2020)
  • Table 117. United States Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 118. United States Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 119. United States Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 120. Canada Pain Patches, by Type USD Million (2015-2020)
  • Table 121. Canada Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 122. Canada Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 123. Canada Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 124. Mexico Pain Patches, by Type USD Million (2015-2020)
  • Table 125. Mexico Pain Patches, by Mode of Administration USD Million (2015-2020)
  • Table 126. Mexico Pain Patches, by Distribution Channel USD Million (2015-2020)
  • Table 127. Mexico Pain Patches, by Therapeutic Use USD Million (2015-2020)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Pain Patches: by Type(USD Million)
  • Table 139. Pain Patches Opioid Patches , by Region USD Million (2021-2026)
  • Table 140. Pain Patches Non-Opioid , by Region USD Million (2021-2026)
  • Table 141. Pain Patches: by Mode of Administration(USD Million)
  • Table 142. Pain Patches Minimally Invasive Microneedle Patches , by Region USD Million (2021-2026)
  • Table 143. Pain Patches Metered Doses , by Region USD Million (2021-2026)
  • Table 144. Pain Patches Active Delivery Systems with Patches , by Region USD Million (2021-2026)
  • Table 145. Pain Patches: by Distribution Channel(USD Million)
  • Table 146. Pain Patches Hospitals , by Region USD Million (2021-2026)
  • Table 147. Pain Patches Drug Stores , by Region USD Million (2021-2026)
  • Table 148. Pain Patches Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 149. Pain Patches Online Pharmacies , by Region USD Million (2021-2026)
  • Table 150. Pain Patches: by Therapeutic Use(USD Million)
  • Table 151. Pain Patches Pain relief , by Region USD Million (2021-2026)
  • Table 152. Pain Patches Anesthesia , by Region USD Million (2021-2026)
  • Table 153. Pain Patches Cough Suppression , by Region USD Million (2021-2026)
  • Table 154. Pain Patches Diarrhea Suppression , by Region USD Million (2021-2026)
  • Table 155. Pain Patches Smoking Cessation , by Region USD Million (2021-2026)
  • Table 156. South America Pain Patches, by Country USD Million (2021-2026)
  • Table 157. South America Pain Patches, by Type USD Million (2021-2026)
  • Table 158. South America Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 159. South America Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 160. South America Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 161. Brazil Pain Patches, by Type USD Million (2021-2026)
  • Table 162. Brazil Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 163. Brazil Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 164. Brazil Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 165. Argentina Pain Patches, by Type USD Million (2021-2026)
  • Table 166. Argentina Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 167. Argentina Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 168. Argentina Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 169. Rest of South America Pain Patches, by Type USD Million (2021-2026)
  • Table 170. Rest of South America Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 171. Rest of South America Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 172. Rest of South America Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 173. Asia Pacific Pain Patches, by Country USD Million (2021-2026)
  • Table 174. Asia Pacific Pain Patches, by Type USD Million (2021-2026)
  • Table 175. Asia Pacific Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 176. Asia Pacific Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 177. Asia Pacific Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 178. China Pain Patches, by Type USD Million (2021-2026)
  • Table 179. China Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 180. China Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 181. China Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 182. Japan Pain Patches, by Type USD Million (2021-2026)
  • Table 183. Japan Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 184. Japan Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 185. Japan Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 186. India Pain Patches, by Type USD Million (2021-2026)
  • Table 187. India Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 188. India Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 189. India Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 190. South Korea Pain Patches, by Type USD Million (2021-2026)
  • Table 191. South Korea Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 192. South Korea Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 193. South Korea Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 194. Taiwan Pain Patches, by Type USD Million (2021-2026)
  • Table 195. Taiwan Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 196. Taiwan Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 197. Taiwan Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 198. Australia Pain Patches, by Type USD Million (2021-2026)
  • Table 199. Australia Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 200. Australia Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 201. Australia Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 202. Rest of Asia-Pacific Pain Patches, by Type USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 206. Europe Pain Patches, by Country USD Million (2021-2026)
  • Table 207. Europe Pain Patches, by Type USD Million (2021-2026)
  • Table 208. Europe Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 209. Europe Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 210. Europe Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 211. Germany Pain Patches, by Type USD Million (2021-2026)
  • Table 212. Germany Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 213. Germany Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 214. Germany Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 215. France Pain Patches, by Type USD Million (2021-2026)
  • Table 216. France Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 217. France Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 218. France Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 219. Italy Pain Patches, by Type USD Million (2021-2026)
  • Table 220. Italy Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 221. Italy Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 222. Italy Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 223. United Kingdom Pain Patches, by Type USD Million (2021-2026)
  • Table 224. United Kingdom Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 225. United Kingdom Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 226. United Kingdom Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 227. Netherlands Pain Patches, by Type USD Million (2021-2026)
  • Table 228. Netherlands Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 229. Netherlands Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 230. Netherlands Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 231. Rest of Europe Pain Patches, by Type USD Million (2021-2026)
  • Table 232. Rest of Europe Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 233. Rest of Europe Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 234. Rest of Europe Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 235. MEA Pain Patches, by Country USD Million (2021-2026)
  • Table 236. MEA Pain Patches, by Type USD Million (2021-2026)
  • Table 237. MEA Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 238. MEA Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 239. MEA Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 240. Middle East Pain Patches, by Type USD Million (2021-2026)
  • Table 241. Middle East Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 242. Middle East Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 243. Middle East Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 244. Africa Pain Patches, by Type USD Million (2021-2026)
  • Table 245. Africa Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 246. Africa Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 247. Africa Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 248. North America Pain Patches, by Country USD Million (2021-2026)
  • Table 249. North America Pain Patches, by Type USD Million (2021-2026)
  • Table 250. North America Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 251. North America Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 252. North America Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 253. United States Pain Patches, by Type USD Million (2021-2026)
  • Table 254. United States Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 255. United States Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 256. United States Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 257. Canada Pain Patches, by Type USD Million (2021-2026)
  • Table 258. Canada Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 259. Canada Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 260. Canada Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 261. Mexico Pain Patches, by Type USD Million (2021-2026)
  • Table 262. Mexico Pain Patches, by Mode of Administration USD Million (2021-2026)
  • Table 263. Mexico Pain Patches, by Distribution Channel USD Million (2021-2026)
  • Table 264. Mexico Pain Patches, by Therapeutic Use USD Million (2021-2026)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pain Patches: by Type USD Million (2015-2020)
  • Figure 5. Global Pain Patches: by Mode of Administration USD Million (2015-2020)
  • Figure 6. Global Pain Patches: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Pain Patches: by Therapeutic Use USD Million (2015-2020)
  • Figure 8. South America Pain Patches Share (%), by Country
  • Figure 9. Asia Pacific Pain Patches Share (%), by Country
  • Figure 10. Europe Pain Patches Share (%), by Country
  • Figure 11. MEA Pain Patches Share (%), by Country
  • Figure 12. North America Pain Patches Share (%), by Country
  • Figure 13. Global Pain Patches share by Players 2020 (%)
  • Figure 14. Global Pain Patches share by Players (Top 3) 2020(%)
  • Figure 15. Global Pain Patches share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Purdue Pharma L.P (United States) Revenue, Net Income and Gross profit
  • Figure 18. Purdue Pharma L.P (United States) Revenue: by Geography 2020
  • Figure 19. Janssen Pharmaceuticals, Inc (Belgium) Revenue, Net Income and Gross profit
  • Figure 20. Janssen Pharmaceuticals, Inc (Belgium) Revenue: by Geography 2020
  • Figure 21. West-Ward Pharmaceuticals Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. West-Ward Pharmaceuticals Corporation (United States) Revenue: by Geography 2020
  • Figure 23. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Pfizer, Inc. (United States) Revenue: by Geography 2020
  • Figure 25. Allergan Plc (Actavis) (Ireland) Revenue, Net Income and Gross profit
  • Figure 26. Allergan Plc (Actavis) (Ireland) Revenue: by Geography 2020
  • Figure 27. Sanofi-Aventis S.A. (France) Revenue, Net Income and Gross profit
  • Figure 28. Sanofi-Aventis S.A. (France) Revenue: by Geography 2020
  • Figure 29. Endo International plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Endo International plc (Ireland) Revenue: by Geography 2020
  • Figure 31. GlaxoSmithKline plc (United States) Revenue, Net Income and Gross profit
  • Figure 32. GlaxoSmithKline plc (United States) Revenue: by Geography 2020
  • Figure 33. Hisamitsu Pharmaceutical Co., Inc (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Hisamitsu Pharmaceutical Co., Inc (Japan) Revenue: by Geography 2020
  • Figure 35. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Mylan N.V. (United States) Revenue: by Geography 2020
  • Figure 37. Global Pain Patches: by Type USD Million (2021-2026)
  • Figure 38. Global Pain Patches: by Mode of Administration USD Million (2021-2026)
  • Figure 39. Global Pain Patches: by Distribution Channel USD Million (2021-2026)
  • Figure 40. Global Pain Patches: by Therapeutic Use USD Million (2021-2026)
  • Figure 41. South America Pain Patches Share (%), by Country
  • Figure 42. Asia Pacific Pain Patches Share (%), by Country
  • Figure 43. Europe Pain Patches Share (%), by Country
  • Figure 44. MEA Pain Patches Share (%), by Country
  • Figure 45. North America Pain Patches Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Purdue Pharma L.P (United States)
  • Janssen Pharmaceuticals, Inc (Belgium)
  • West-Ward Pharmaceuticals Corporation (United States)
  • Pfizer, Inc. (United States)
  • Allergan Plc (Actavis) (Ireland)
  • Sanofi-Aventis S.A. (France)
  • Endo International plc (Ireland)
  • GlaxoSmithKline plc (United States)
  • Hisamitsu Pharmaceutical Co., Inc (Japan)
  • Mylan N.V. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation